Agilent named among top workplaces by Fortune in healthcare

85% of Agilent employees who responded to the survey indicated that the company is a great place to work

Merck invests € 130 million + to strengthen manufacturing capabilities in France

Investment further strengthens Merck's "Big 3," the key drivers for increasing Group sales to approximately € 25 billion by 2025

Lynparza with Bevacizumab demonstrates survival in certain patients with first-line advanced ovarian cancer

The Phase 3 SOLO-1 trial demonstrated 67% of advanced ovarian cancer patients with BRCA mutations receiving LYNPARZA were alive at seven years versus 47% of placebo patients

Healthcare sector is expected to reach US $50 bn by 2025

Healthcare has become more focused on innovation and technology over the past two years and 80% of healthcare systems are aiming to increase their investment in digital healthcare tools in the coming five years

Boehringer Ingelheim InPedILD Phase III trial showed encouraging results for both primary endpoints

New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease

Aurionpro acquires US based startup Hello Patients

Hello Patients provides healthcare billing and patients’ management solution

Centre grants approval of three Bulk Drug Parks

The Bulk Drug Parks to be developed under the scheme will provide common infrastructure facilities at one place thereby creating a robust ecosystem for the bulk drug manufacturing in the country and also reducing manufacturing cost significantly

USFDA completes inspection at Aurolife Pharma’s Raleigh unit

The unit has filed 2 Derma products and 1 MDI product.

Lupin and I'rom signs licensing agreement for Denosumab biosimilar for Japan

3Brain AG's Accura-3D microchip, enters the market

3D CMOS chip for connecting electroactive tissues and organoids to software